KI
AMPH icon

Kula Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

Kula Investments’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,236
Closed -$287K – 593
2022
Q4 		$287K Buy
+10,236
New +$297K 0.08% 402

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Kula Investments's AMPH Position: Q1 2023 in Review

Kula Investments sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2023, closing a stake of 10,236 shares — an estimated $287K sold.

Kula Investments first reported a position in AMPH in Q4 2022 and held it in 1 quarter. The position peaked at $287K in Q4 2022. 218 funds tracked by Wall St. Rank hold AMPH as of Q1 2023.

  • Kula Investments reported no remaining Amphastar Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Kula Investments sold 10,236 Amphastar Pharmaceuticals shares in Q1 2023, an estimated $287K.
  • Kula Investments first reported a position in Amphastar Pharmaceuticals in Q4 2022 and held it in 1 quarter.
  • Kula Investments's Amphastar Pharmaceuticals position peaked at $287K in Q4 2022.
  • 218 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.